Details for 2020209073

Up to date per 01.04.2026

Actions

Title / Product Name

GENETISCH MODIFIZIERTE MÄUSE ZUR EXPRESSION VON MENSCHLICHEM EPO

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020209073

EP Publication Number

3841877

E-Number

1607224

Language

PCT Number

Publication Date

30.06.2021 A

06.09.2023 B1

Registration Date

06.09.2023

AT Publication Date

15.09.2023

Application Date

18.05.2015

Registration Number

Priorities

19.05.2014

201462000460 P

IPC

A01K 67/027 20060101AFI20210430BHEP

Maximum Duration of Protection

18.05.2035

Owner

Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River Road Tarrytown, NY 10591-6707US

Yale UniversityTwo Whitney Avenue New Haven, CT 06510US

Institute for Research in Biomedicine (IRB)Via Francesco Chiesa 5 6500 BellinzonaCH

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT

Inventor

MURPHY, Andrew J.c/o Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown, CT 10591US

STEVENS, Sean12848 Caminito De Las Olas Del Mar, CT 92014US

FLAVELL, Richard283 Moose Hill Road Guilford, CT 06437US

MANZ, MarkusDirektor Klinik für Hämatologie Universitätsspital Zürich Raemistrasse 100 8091 ZürichCH

SHAN, Liang432 Carswold Drive St. Louis, MO 63105US

Information about Fees